Prevalence and incidence of carpal tunnel syndrome in US working populations: pooled analysis of six prospective studies

Abstract

Objectives

Most studies of carpal tunnel syndrome (CTS) incidence and prevalence among workers have been limited by small sample sizes or restricted to a small subset of jobs. We established a common CTS case definition and then pooled CTS prevalence and incidence data across six prospective studies of musculoskeletal outcomes to measure CTS frequency and allow better studies of etiology.

Methods

Six research groups collected prospective data at >50 workplaces including symptoms characteristic of CTS and electrodiagnostic studies (EDS) of the median and ulnar nerves across the dominant wrist. While study designs and the timing of data collection varied across groups, we were able to create a common CTS case definition incorporating both symptoms and EDS results from data that were collected in all studies.

Results

At the time of enrollment, 7.8% of 4321 subjects met our case definition and were considered prevalent cases of CTS. During 8833 person-years of follow-up, an additional 204 subjects met the CTS case definition for an overall incidence rate of 2.3 CTS cases per 100 person-years.

Conclusions

Both prevalent and incident CTS were common in data pooled across multiple studies and sites. The large number of incident cases in this prospective study provides adequate power for future exposure– response analyses to identify work- and non-work-related risk factors for CTS. The prospective nature allows determination of the temporal relations necessary for causal inference.

Carpal tunnel syndrome (CTS) is the most expensive upper-extremity musculoskeletal disorder (UEMSD) at an estimated cost of medical care in the US exceeding $2 billion annually, primarily due to surgical releases (1). The non-medical costs are substantially greater. In the US, the median lost worktime from work-related CTS is 27 days, which is longer than any other work-related disorder except fractures (2, 3). Furthermore, 18% of workers who develop CTS reported leaving their job within 18 months (4). Although CTS is a strong driver of workers’ compensation costs, lost wages, lost productivity, and disability (1, 2), there is still an incomplete understanding of its frequency and causes in working populations.

Estimates of CTS prevalence and incidence vary widely in the literature. The prevalence of electrophysiologically confirmed CTS in working populations is generally higher than in the general population. Prevalent CTS among manufacturing and meat-packing workers has ranged from 5–21% (5–8) while prevalence proportions in general populations range from 1–5% (9–12). The data source, study design, and CTS case definition may have large effects on the measured prevalence proportions. Incidence rates of CTS calculated from Washington State workers’ compensation records ranged from 0.8–14.8 per 1000 person-years and varied by industrial and occupational classifications (13). Similar rates of 12.4 per 1000 person-years were observed among 432 industrial and clerical workers using a case definition requiring electrodiagnostic confirmation (14).

Relatively few prospective studies have examined the relationships between work and non-work factors and new cases of incident CTS. To our knowledge there is only one large prospective study that has done so – Bonfiglioli and colleagues (15) studied a population of 4097 workers assessed prospectively for CTS and found a dose–response relationship between the American Conference of Governmental Industrial Hygienists threshold limit values (ACGIH TLV) classification and risk for CTS. While growing evidence suggests that work activities are associated with CTS, most studies have been limited by retrospective or cross-sectional design, non-specific case definitions, or imprecise exposure assessment (16–17). Such limitations in past studies have led some authors to state that workplace factors pose an “uncertain relationship to CTS” (18) while other studies have concluded that up to 50% of CTS cases are caused by work and could be prevented (19). Such causal uncertainty has likely delayed prevention efforts.

The relatively low incidence rates of CTS and the difficulties experienced when quantifying workplace exposures has made investigations of CTS causation quite challenging. Many large epidemiologic studies of electrodiagnostically confirmed CTS have estimated occupational exposure to physical risk factors with imprecise methods such as job titles or self-reported exposures (11, 20–21). Conversely, studies using detailed observational or direct methods for quantifying workplace exposures have been limited to smaller samples or single occupations (14–15, 22–25). While meta-analyses and systematic reviews can combine or compare studies of similar design, differences in design detail may limit their validity (26). By contrast, pooling data across studies can provide larger sample sizes and allow for direct examination of the comparability of data sources and methods.

In 2000, the US National Institute for Occupational Safety and Health (NIOSH) announced the availability of funding for prospective studies to evaluate the relationship between workplace factors and UEMSD, including CTS. Seven NIOSH-funded research groups formed the UEMSD Consortium to collaborate on studies of physical exposures and UE health outcomes, as well as to improve the potential for data pooling. All studies were prospective in design and collected symptom information, physical examination findings, and electrodiagnostic study (EDS) results to ascertain prevalent and incident MSD outcomes. In addition, all studies collected detailed workplace physical exposure data on all subjects.

In 2009, the UEMSD consortium received funding from NIOSH to pool data from six of the seven studies. Methods used to pool workplace physical exposure data have been described elsewhere in a manuscript by Kapellusch and colleagues, authors from the UE MSD consortium (27). The objectives of the present paper are to (i) describe the data available for establishing a common CTS case definition from six of the original consortium groups, (ii) describe the comparability of data elements across studies, and (iii) present the CTS prevalence and incidence rates for each study group and for the pooled cohort. This is the first in a series of papers describing CTS in this large, multi-center, prospective cohort study of workplace exposures and CTS.

Methods

Study population

Subjects in all studies were fulltime male and female employees aged ≥18 years, who were employed in settings where some or all workers performed hand-intensive activities. Subjects were recruited primarily from industries representing manufacturing, production, service, construction, and healthcare. Approximately 18% of the workers performed jobs of lower hand intensity, including clerical and technical workers. In total, workers were recruited from >50 employers or building trade unions across the six study groups. Data collection began in 2001 and ended in 2010. The respective institutional review boards approved the studies and written informed consent was obtained from all participants.

Study design

All study groups administered baseline questionnaires on demographics, medical history, psychosocial factors, work history, and musculoskeletal symptoms. The duration of each study ranged from 2–7 years. Symptom information was collected at regular intervals in all studies, though the length of intervals varied between one week and one year between studies (figure 1). The number of follow-up symptom assessments collected from each subject ranged from 3–147 depending upon the frequency of questionnaires and duration of each follow-up. In five groups, EDS of the median and ulnar nerves of the wrist were collected along with UE physical examinations for all subjects at baseline. The sixth study group (Study D) performed baseline EDS only on those subjects who reported symptoms characteristic of CTS. Three studies (Studies A, E, F) performed bilateral EDS while the other studies performed unilateral EDS of the dominant hand. Follow-up EDS were administered at predefined periodic intervals in five studies (Studies A, B, D, E, F). Two of these studies also performed EDS following report of new hand symptoms (Studies C & E). The sixth study (D) only performed follow-up EDS among subjects with new hand symptoms. In all study groups, outcome assessors were blinded to the exposure status of the subjects.

Figure 1.

Data collection and study design for six original studies (A–F). NCS=nerve conduction study.

CTS hand symptom definition

Hand symptoms and onset date were assessed using surveys or interviews at frequencies ranging from weekly to annually. For three studies (A, B, F), subjects who reported positive symptoms by survey were asked to fill out a hand symptom diagram to show the location of symptoms and describe the type of symptoms experienced in the hand. Hand diagrams were coded following a standard or modified Katz scoring system (28, 29), which have shown excellent inter-rater and intra-rater reliability and validity in methodological studies performed by two of the study groups (30, 31). For studies using hand diagrams, the CTS hand symptom case definition for the pooled study required subjects to report characteristic symptoms in ≥1 median innervated digit (ie, a hand diagram consistent with classic, probable, or possible CTS). The remaining three studies (C, D, E) interviewed all subjects who reported recent hand symptoms in order to determine the location and type of symptoms. The CTS hand symptoms case definition required that subjects report symptoms of tingling, numbness, burning, or pain in ≥1 of the first three digits (thumb, index finger, or long finger) (table 1).

Table 1.

Baseline description of symptom data collection methods for each study.

Study groups	Assessment type	Method	Symptom type a	Digits with symptoms b	Symptoms in one or more digits	Baseline assessment of symptoms	Follow-up symptom assessments	Symptom assessments per subject
								Mean	Range
A	Survey	Hand diagram	N, T, B, P	(1/2/3)	Yes	Yes	Annually	2.7	1–3
B	Survey	Hand diagram	(B), (N/T), (N/T/P)	(1/2/3)	Yes	Yes	Every 4 months	7.2	1–11
C	Interview	Type and location of symptoms	(N/T/B/P)	(1/2/3)	Yes	Yes	Every 4 months	4.6	1–12
D	Interview	Type and location of symptoms	N, T, B, P	(1/2/3)	Yes	Yes	Weekly	45.6	1–147
E	Interview	Type and location of symptoms	(N/T)	1, 2, 3	Yes	Yes	Monthly	45.3	1–75
F	Survey	Hand diagram	(N/T), (B/P)	(1/2/3)	Yes	Yes	6 & 18 & 36 months	4.6	1–5

^aSymptom type: N=numbness, T=tingling, B=burning, P=pain; combined descriptors listed in parentheses ()

^bDigit number: 1=thumb, 2=index finger, 3=long finger

Electrodiagnostic procedures

All studies collected median nerve motor and sensory and ulnar nerve sensory conduction latencies across the wrist (table 2). Four study groups used conventional electrophysiology/electromyography equipment (XLTEC Neuromax 1002, Cadwell, Oxford Synergy, Teca Sapphire2P) and two studies used a portable nerve testing device (NC-stat, Neurometrix Inc, Waltham, MA, USA). A previous comparison of measures made with conventional equipment and the NC-stat devices showed good correlation of median motor and sensory nerve conduction latencies between measures (32). All study groups followed recommended electrodiagnostic testing protocols (10).

Table 2.

Baseline description of nerve conduction studies data collection methods for each study. [EDS=electrodiagnostic studies; NCS=nerve conduction study; n/a=not available]

Study groups	EDS device	Temperature location recording	Trigger temperature for hand warm	Electrode distance measurement	Sensory latency recording	Median nerve test digit	Ulnar nerve test digit	Baseline assessment of NCS	Follow-up frequency of NCS	Frequency of NCS per subject
										Mean	Range
A	XLTEC Neuromax 1002	Mid-palm	32 °C	Premeasured a	Peak	Index	Small	Yes	Annually	2.7	1–3
B	Cadwell Sierra II	Dorsal hand	32 °C	Premeasured a	Peak	Index	Small	Yes	Annually	3.1	1–4
C	NCstat	Volar wrist	31 °C	Directly measured	Peak	Long	Small	Yes	Annually and symptoms at 4 months triggered NCS	2.4	1–6
D	Teca Sapphire2P	Mid-palm	32 °C	Directly measured	Onset	Index	Small	If triggered by symptoms	Weekly symptoms triggered exam; symptoms of median nerve triggered NCS	1.4	1–4
E	TECA Synergy	Dorsal hand	30 °C /32 °C b	Directly measured	Peak	Long	Small	Yes	All tested at 4 & 7 years and monthly symptoms triggered NCS	3.3	1–11
F	NCstat	Volar wrist	n/a	Directly measured	Peak	Long	Small	Yes	All tested between 3–5 years	1.8	1–2

^aSensory test distance-14 cm, motor test distance-8cm.

^b700 subjects were tested with hand warming triggered <30 °C; all others were tested with 32 degrees.

Electrode distance measures

Procedures for recording the conduction distance between the stimulus and response electrode allowed standardizing of latency values. Two studies (A & B) used predetermined distances between stimulating and recording electrodes for sensory (14 cm) and motor (8 cm) latency measurement. The remaining studies placed electrodes with reference to anatomical landmarks and recorded distances between them. The sensory latency values were adjusted to a standard distance of 14 cm using the following equation: corrected sensory latency = [(measured sensory latency/measured distance) × 14 cm]. In a similar way, the motor latency values were adjusted to a standard distance of 8 cm using the following equation: corrected motor latency = [(measured motor latency/measured distance) × 8 cm]. The NC-stat device uses a volume conduction methodology for measuring motor latency so length adjustments were not applied to these median motor latency values (31, 33).

Temperature and waveform corrections

All studies measured and recorded skin temperature prior to testing. The location of temperature measurement differed between studies: two studies measured temperature at the palm, two at the volar wrist, and two on the dorsum of the hand. Five of six study groups used warming procedures to reach a minimum specified skin temperature (30–32 ° C). To correct latency values for differences in recorded temperatures, regression analyses were conducted to estimate the change in latency per degree change in temperature. Analyses were performed separately for each study using data from all asymptomatic subjects whose values fell within three standard deviations of the mean latency for that study group. Nerve conduction latency values were corrected to 32 ° C by using the betas derived from the regression equations and applied to data from the corresponding study. Corrections for nerve conduction latencies across studies ranged from 0–0.10 ms per degree <32 ° C.

Sensory latency values were measured from stimulation artifact to the onset of the sensory nerve action potential by one study, while the remainder measured sensory latency to peak of the sensory nerve action potential. A correction of 0.5 ms was added to the onset sensory latency so values were comparable to the peak sensory nerve values. Since all of the motor latencies were recorded to the onset of the compound motor action potential, no adjustments were made. Temperature and electrode distance-adjusted median motor and median sensory and ulnar sensory nerve conduction latencies were used for electrophysiological confirmation of CTS.

CTS case definition

The CTS case definition used in the pooled study analysis required both CTS hand symptoms and EDS results consistent with median nerve mononeuropathy at the wrist (34). A pooled dataset, including hand symptoms and EDS values was assembled from results obtained by each study. The adjustments to EDS results were made prior to the creation of the pooled dataset. Cut-off points for defining nerve conduction abnormalities consistent with median mononeuropathy at the wrist were based on review of the relevant literature and analyses within consortium studies (15, 35–38). Specifically, the electrophysiological case definition of median mononeuropathy of the wrist used for the pooled analysis of the dominant hand was: (i) peak median sensory latency >3.7 ms (at 14 cm) or absent response or (ii) median motor latency >4.5 ms or (iii) paired transcarpal median-ulnar sensory delta of >0.85 ms (14 cm) (defined as the difference in sensory latency of the median to the ulnar nerve). Unobtainable latency results that were due to nerve pathology (extremely prolonged latencies or very small amplitudes) also met the criteria for abnormal EDS in the case definition.

Polyneuropathy of the upper extremity

To distinguish subjects with polyneuropathy from those with CTS, we identified subjects with ulnar sensory nerve peak latencies of ≥3.68 ms. This value corresponds to an ulnar sensory nerve conduction velocity of 44 m/s, a commonly used lower bound of normal ulnar sensory nerve conduction velocity (38). Subjects with abnormal ulnar sensory latencies who also met the CTS case definition were excluded from the CTS case count and censored at that time.

Prevalence analysis

Subjects meeting electrophysiological criteria for polyneuropathy at baseline were eliminated from further analysis (N=58). Subjects who met the pooled CTS study case definition for the dominant hand or reported prior carpal tunnel release (CTR) surgery at the time of entry into study were identified as prevalent CTS cases. The number and proportion of prevalent cases are reported for both the pooled cohort and separately for each study.

Incidence analysis

The incidence analysis included all subjects at risk of becoming a new CTS case during follow-up. Each subject contributed person time to the CTS incidence analysis until he/she (i) completed the study, (ii) was lost to follow-up (dropped-out), (iii) became an incident CTS case, or (iv) became an incident polyneuropathy case. Subjects were considered to have met the CTS case definition of median nerve symptoms and abnormal EDS on the date they met symptom criteria up to four months prior to the date of the confirmatory EDS. One study (D) used the presence of characteristic symptoms to trigger EDS testing. Three studies (A, B, F) performed EDS testing for all subjects at predetermined time points, regardless of reported symptoms on interim surveys, and two studies (C and E) performed EDS testing at predetermined time points as well as when triggered by symptoms. All analyses were conducted using STATA (StataCorp, College Station, TX, USA).

Results

A total of 4321 subjects were enrolled across the six studies (tables 3A and 3B). Education, race and ethnicity, age, and body mass index differed across study samples. The percentage of college graduates ranged from 0.7–20.6%, and the percentage of Caucasian study subjects ranged from 8.2–92.7%. While the pooled study sample overall had nearly equal numbers of males and females, the proportion of male subjects ranged from 36–65% across individual studies. Mean age at enrollment ranged from 30.8–43.4 years across studies. The average duration of employment was 6.2 years at baseline; while most studies enrolled current workers, one study (F) enrolled only newly hired workers who were generally younger. The majority of the workers were from manufacturing companies (64.0%) while others worked in construction, agriculture, healthcare, technical professions, and service work. The manufactured products included vehicles, household appliances, furniture, artificial stone, metal products, machinery, books, textiles, and dairy and food products.

Table 3.

A. Baseline demographics and characteristics of categorical variables of each study
	Study groups
	A N=482	B N=720	C N=447	D N=346	E N=1219	F N=1107	Total N=4321
	%	%	%	%	%	%	%
Gender
Male	55.6	51.9	64.0	47.7	34.0	65.0	51.5
Female	44.0	48.1	36.0	52.3	66.0	35.0	48.4
Missing values	0.4	0.0	0.0	0.0	0.1	0.0	0.1
Hand dominance
Right hand dominant	90.5	91.7	95.5	88.2	92.0	89.4	91.2
Missing values	0.4	0.0	1.6	0.0	0.0	0.5	0.3
Education
Some high school or less	5.2	16.8	69.4	2.0	11.2	7.6	15.8
Graduated high school	81.1	73.8	28.2	92.8	82.7	71.7	73.4
College graduate or above	13.3	9.4	0.7	4.0	3.7	20.6	9.8
Missing values	0.4	0.0	1.8	1.2	2.5	0.1	1.0
Ethnicity
Caucasian	68.7	59.4	8.3	91.9	42.8	61.2	53.5
Hispanic	3.7	13.2	83.2	0.9	9.8	0.7	14.2
African American	22.8	3.9	1.6	4.0	4.0	34.1	13.6
Asian	1.2	17.9	1.3	2.3	1.5	2.1	4.4
Other	1.2	5.6	2.2	0.0	3.2	1.6	2.6
Missing values	2.3	0.0	3.4	0.9	38.7	0.3	11.7
Current medical condition
Diabetes	4.6	3.6	6.3	1.7	5.3	2.6	4.1
Rheumatoid arthritis	1.2	1.1	2.5	1.2	4.0	1.3	2.1
Thyroid disease (hyper/hypo)	7.3	5.0	0.9	6.4	6.9	2.4	4.8
Pregnancy	0.2	1.4	0.2	0.3	0.6	-	0.5

B. Baseline demographics and characteristics of continuous variables of each study. [SD=standard deviation.]
	Study groups
	A N=482		B N=720		C N=450		D N=346		E N=1220		F N=1107		Total N=4321
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD
Age at enrollment	41.1	10.8	39.5	10.9	38.6	11.2	43.4	10.0	42.7	11.4	30.9	10.3	38.5	11.8
Body mass index (kg/m2)	29.6	6.5	27.3	5.8	28.7	4.7	27.5	5.5	29.4	6.7	28.5	6.5	28.6	6.3
Years employed at enrollment	6.7	4.5	6.3	7.0	6.1	5.7	16.4	11.1	10.0	9.4	0.2	0.3	6.5	8.3

Table 4 shows the prevalence of symptoms, median mononeuropathy, and CTS at baseline. Overall, 15.2% of the subjects met the hand symptom criteria at baseline, with a range of 6.0–24.0% across the research studies, with the lowest frequency among subjects from study F, which recruited the youngest workers with the shortest job tenure at the time of evaluation. Overall, 31.0% of subjects had an abnormal EDS at baseline. Polyneuropathy, defined as those with abnormal ulnar sensory latency in addition to CTS, was uncommon (1.4%). Prevalent CTS (ie, those meeting the pooled study CTS case definition or having a prior history of CTR) ranged from 2.6–14.0% at baseline across studies with 7.8% of the pooled cohort meeting the CTS case definition of symptoms and EDS abnormalities. Prevalent CTS was higher among females than males [10.0%, 95% confidence interval (95% CI) 8.7–11.3% versus 5.8%, 95% CI 4.8–6.8%]. The proportion of prevalent CTS increased with older age categories: <30 (3.7%), 30–<40 (6.4%), 40–<50 (10.7%), and ≥50 years (11.9%).

Table 4.

Prevalence of carpal tunnel syndrome (CTS) of the dominant hand at baseline for each study. [CTR=carpal tunnel release or surgery; MUDS=median-ulnar sensory difference; 95% CI=95% confidence interval]

	Study groups
	A N=482		B N=720		C N=447		D N=346		E N=1219		F N=1107		Total N= 4321
	N	%	N	%	N	%	N	%	N	%	N	%	N	%	95% CI
Prevalent polyneuropathy a	9	1.9	2	0.3	3	0.7	0	0	41	3.8	3	0.3	58	1.4	1.0–1.7
Median nerve symptoms b	105	21.8	107	14.9	56	12.5	30	8.7	293	24.0	66	6.0	657	15.2	14.2–16.3
Median mononeuropathy c	232	48.5	186	25.8	116	26.3	23	6.6	484	45.6	193	17.6	1234	31.0	29.6–32.4
CTS case definition d	60	12.4	45	6.3	23	5.1	21	6.1	125	10.3	29	2.6	303	7.1	6.3–7.8
Prior CTR reported at baseline	5	1.0	3	0.4	6	1.3	1	0.3	22	1.8	0	0.0	37	0.9	0.6–1.1
Prevalent CTS cases e	64	13.3	48	6.7	29	6.6	22	6.4	146	14.0	29	2.6	338	7.8	7.1–8.6

^aPolyneuropathy criteria: onset sensory-recorded wave – CTS case definition AND ulnar sensory latency >3.18 ms; peak sensory-recorded wave CTS case definition AND ulnar sensory latency > 3.68 ms.

^bMedian nerve symptom criteria: numbness, tingling, burning or pain in≥1 digits (thumb, index, long).

^cMedian neuropathy critera: onset sensory-recorded wave – median nerve symptoms AND [(median sensory latency >3.2 ms or absent) or median motor latency > 4.5 ms or MUDS >0.85 ms]; peak sensory-recorded wave – median nerve symptoms and [(median sensory latency >3.7 ms or absent) or median motor latency > 4.5 ms or MUDS >0.85 ms].

^dCTS case definition criteria: median nerve symptoms and median neuropathy of the dominant hand.

^ePrevalent CTS case: CTS case definition or prior CTR reported at baseline.

After excluding prevalent cases of CTS and polyneuropathy as well as the subjects with no follow-up measurements, 3515 workers were eligible for inclusion in the analysis of CTS incidence (figure 2). In the pooled analysis, 204 incident cases of CTS were observed across 8833 total person-years of observation, resulting in an incidence rate of 2.3 cases per 100 person-years (table 5). The CTS incidence rate varied considerably across studies, from 0.7 cases per 100 person-years (Study F) to 5.6 cases per 100 person-years (Study A). In the pooled cohort, the incidence rate of CTS symptoms was 9.3 per 100 person-years and the incidence rate of median mononeuropathy was 4.0 per 100 person-years.

Figure 2.

Selection of sample for the incidence analysis

Table 5.

Incidence of carpal tunnel syndrome (CTS) of the dominant hand for each study. [EDS=electrodiagnostic studies; IR=incident rate; 95% CI=95% confidence interval]

	Study Groups
	A		B		C		D		E		F		Total
	N	IR	N	IR	N	IR	N	IR	N	IR	N	IR	N	IR	95% CI
Original population	482		720		447		346		1219		1107		4321
Sample at risk for incident CTS	357		592		392		294		884		996		3515
CTS case definition a	34		47		17		12		70		24		204
Person time (in person years)	605		1145		503		244		2681		3657		8833
Censored due to polyneuropathy b	6		0		0		0		20		2		28
Censored due to symptoms and no EDS c	5		9		2		0		79		64		159
Incident rate (per 100 person years)		5.6		4.1		3.4		4.9		2.6		0.7		2.3	2.0–2.7

^aCTS case definition criteria: median nerve symptoms and median neuropathy of the dominant hand

^bPolyneuropathy criteria: onset sensory-recorded wave – CTS case definition and ulnar sensory latency >3.18 ms; peak sensory-recorded wave – CTS case definition and ulnar sensory latency >3.68 ms.

^cSubjects with positive reported symptoms that did not have another electrodiagnostic study (EDS) were censored at the time of the symptoms.

Of the 159 subjects in the incidence analysis who became symptomatic but did not receive a follow-up EDS within four months, most came from studies E and F (N=143). Because some of these subjects would have likely met the pooled study criteria for CTS if they had been administered EDS, the observed incidence estimates for these two studies is likely an underestimate of the true incidence. To explore the extent of such underestimation, we first calculated the proportions of symptomatic subjects who met the EDS case definition for median mononeuropathy separately for each study. The proportions of symptomatic subjects who met the EDS criteria for median mononeuropathy were 34.2% and 28.6 % for Study E and F, respectively. From this information, we calculated the number of subjects with positive symptoms expected to have met the CTS case definition, had an EDS been obtained. An estimated additional 27 and 18 incidence cases would have been observed for Study E and F, respectively. These additional cases would have increased the adjusted incident rates to 3.6 and 1.2 per 100 person-years for Study E and F, respectively, rates more consistent with the other study groups.

Discussion

By pooling data from six research studies, more stable estimates of CTS frequency were possible than were estimates from each of the individual studies. In order to best characterize CTS frequency, a pooled study case definition was created that required both characteristic symptoms and EDS confirmation of median nerve mononeuropathy at the wrist. The prevalence of CTS was 7.8% among the members of this pooled cohort of 4321 mostly industrial workers with higher proportions among females and older age categories. Incident CTS was observed among 5.8% of 3515 workers, who contributed any person time to the analysis resulting in an incidence rate of 2.3 per 100 person-years.

Previous studies of CTS have reported widely varying prevalence and incidence rates of CTS. While CTS rates depend on the physical exposures and other characteristics of the population under study, they are also affected by the study design and CTS case definitions used to define the disease (40). Case definitions based on symptoms alone lead to higher estimates of disease prevalence compared to definitions requiring both symptoms and EDS confirmation (37). Cross-sectional studies using case definitions based solely on characteristic hand symptoms of CTS have reported prevalence proportions of CTS from 11–31% (8, 41), which are similar to the prevalence of symptoms of 15.2% for this pooled study. Yet lower prevalence proportions between 3–11% were found for studies with case definitions requiring both symptoms and nerve conduction abnormalities (8, 12), similar to the 7.8% prevalence observed in the current pooled analysis. Case definitions that include symptoms and median mononeuropathy abnormalities are considered to be more specific for CTS (11, 34, 42, 43).

The 7.8% prevalence of CTS in our study is comparable to those reported in past studies. The cohort comprised of new hires (Study F) had the lowest CTS prevalence (2.6%). Prevalent CTS in working populations also differ by the type of work. Studies of manufacturing workers that used a case definition of symptoms and abnormal EDS have reported prevalence between 5.6–11.9% (6, 44). High proportions have also been observed among construction (8.2%), poultry (8.9%) and dairy workers (16.6%) (45–47). The pooled cohort in the current study consisted largely of workers from manufacturing (64%) with subsets from service and construction industries as well as jobs of lower hand intensity including clerical and technical positions.

CTS incidence rates in previous studies have depended in part on the use of active versus passive surveillance methods to identify cases. Passive surveillance approaches, such as the use of workers’ compensation data, results in observed annual CTS incidence rates that range from 0.04–0.2 per 100 person-years, varying by occupation or industry (13, 21). Active surveillance approaches, such as the few longitudinal studies that screened all members of a defined cohort for symptoms and nerve conduction abnormalities, results in higher observed CTS incident rates. Gerr and colleagues screened clerical workers on a weekly basis and observed an annual incidence of CTS of 0.91 per 100 person-years (48). A prospective study of industrial and clerical workers showed an incidence of 1.24 per 100 person-years (14). The current study found an incidence rate of 2.3 per 100 person-years in the pooled cohort. More of the workers represented in the pooled cohort were employed in jobs requiring hand-intensive activities than in the Gerr (48) or Gell (14) studies. The frequent screening of workers over time provides for the most complete monitoring for the development of symptoms and opportunities for confirmation with electrodiagnostic testing.

The strengths of this analysis include the detailed comparisons of the data collection methods for CTS case definitions used by six distinct studies and the creation of a single large dataset for use in the pooled analyses. The results of this pooling have produced a well-characterized and diverse cohort of 4321 workers with a large number of incident and prevalent CTS cases. These data provide adequate power for future exposure response analysis to adjust for confounding and assess interactions. The geographic variability and variety of work types included in this pooled cohort will increase the generalizability of future analyses of these data. This pooled dataset will enable future studies that can address some of the limitations seen in many past studies, including reliance on retrospective methods (49, 50), small sample sizes, non-representative samples of workers and industries, lack of adequate baseline assessments in the few reported cohort studies, and lack of objective outcomes measures including nerve conduction measurements, the definitive physiological indicator of CTS (51, 52).

Several important challenges were encountered when pooling the health outcomes data for this study. Test procedures varied across studies. Hand temperature measurements were recorded in different locations of the hand and the warming procedures were not uniform. We attempted to adjust for this difference by normalizing results for temperature based on the data from within each study. The use of six nerve testing devices may have introduced an instrument bias since reliability testing between devices was not performed, However the devices used in the six studies are all widely accepted and commonly used in clinical and research settings. Measurements taken with the portable nerve testing device used at two studies (NC-stat) have been shown to correlate well with traditional nerve testing (32, 53). The differences in frequency of symptom assessment and nerve conduction studies (NCS) between studies may have affected the sensitivity of case detection between studies. Because symptoms of CTS can vary over time, studies that assessed symptoms more frequently may have detected more cases than those assessing symptoms less frequently. The symptom data were collected across all studies using the same symptom qualities (numbness, tingling, burning, or pain), and location, though symptom questions were posed to subjects in different ways.

As described above, there were differences among the six studies in the frequency of subject assessment and the protocols used to collect symptom and EDS results. However, important similarities across these research studies allowed us to create a common case definition of CTS for use in a pooled longitudinal analysis. This large pooled cohort allowed us to estimate both prevalence and incidence rates of CTS in this large and varied sample of working men and women. Most importantly, these pooled CTS outcomes data can now be paired with detailed individual exposure data from the same cohort to allow for a powerful analysis of exposure–response relationships between work-related and individual factors and CTS incidence.